Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT07132788
- Status
- Recruiting
Conditions
- Pulmonary Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- blood draw — DIAGNOSTIC_TESTResearch blood draw
- Short Performance Physical Battery — DIAGNOSTIC_TESTtest of physical performance, which involves measuring movement from sitting to standing, walking speed, and balance
- Grip strength test — DIAGNOSTIC_TESTMeasures grip strength
- Six minute walk test — DIAGNOSTIC_TESTMeasures distance walked in 6 minutes
- Chest CT scan — RADIATIONX-ray and computer technology takes detailed pictures of the organs and structures inside your chest
- Dual-Energy X-ray Absorptiometry Scan — RADIATIONUses X-ray technology to measure the mineral density of your bones, and provides a ratio of fat tissue to lean mass (muscle) and bone
- Activity monitoring — BEHAVIORALA device worn on your non-dominant wrist which measures motion/ movement/ activity
- 24 hour diet recall — BEHAVIORALA research dietitian will contact you and ask you to provide details of what you ate over the previous 24 hours
- Echocardiogram — DIAGNOSTIC_TESTUltrasound technology to create moving images of your heart, valves, and chambers
- Quality of Life Questionnaire (emPHasis 10) — BEHAVIORALThe emPHasis-10 is a pulmonary hypertension-specific questionnaire which is scored from 0-50 (with higher scores indicating worse quality of life.)
- International Physical Activity Questionnaire Short Form (IPAQ-SF) — BEHAVIORALThe IPAQ-SF is a small set of questions to obtain comparable estimates of physical activity.
- Low resistance exercise intervention — BEHAVIORALParticipants will be asked to perform a series of exercises recommend by the National Institute on Aging Go4Life campaign, namely hand grip, overhead arm raise, arm curl, wall push-ups, and chair dips.
Study Details
Patients with pulmonary arterial hypertension (PAH) are at increased risk of muscle loss and decreased physical activity. This study will aim to (1) understand the way in which muscle loss occurs in PAH, particularly the role of fat surrounding the heart, and (2) look at the impact muscle loss has on quality of life, daily physical activity, and hospitalizations in patients with PAH. The findings from this study could help identify potentially treatable factors that may improve the overall quality of life and physical functioning of patients with PAH. Subjects will be asked to attend a baseline visit where the following will be performed: * Measure your vital signs * Undergo a research blood draw, less than 4 tablespoons * Provide a urine pregnancy test (if applicable) * Review demographics, personal history, and medical history * Review current PAH medications * Complete questionnaires on how your PAH affects you * Complete a test of physical performance * Complete a grip strength test * Undergo an echocardiogram (Echo) * Complete a six-minute walk test * Undergo a Chest CT Scan * Undergo a scan of your body composition (DXA scan) * Obtain a weight and body composition measurement on the InBody Scale Subjects will also complete activity moniotring, two 24-hour diet recalls, and participate in remote follow-up visits every 6 months
Key Dates
- Start date
- May 1, 2025
- Status verified
- May 2026
- Primary completion
- Sep 30, 2029
- Completion
- Sep 30, 2029
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: Low resistance exercise interventionParticipants will be asked to perform a series of exercises recommend by the National Institute on Aging Go4Life campaign, namely hand grip, overhead arm raise, arm curl, wall push-ups, and chair dips.
Primary Outcome Measure
Intake of food and nutrients [ Time Frame: One time at Baseline ]
Central Contacts
- Rebecca Gallagher215-294-9755
- Nicole Denney, MS215-615-4156
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pennsylvania Hospital | Philadelphia | Pennsylvania | 19104 | Nicole Denney, MS Nadine Al-Naamani, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
Related Studies
- Metformin for Pulmonary Hypertension HFpEFPHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- Autologous Stem Cell Transplantation in Patients With Systemic SclerosisPHASE2 · Recruiting · Paul Szabolcs · Pittsburgh, Pennsylvania
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pulmonary Hypertension Association RegistryRecruiting · Pulmonary Hypertension Association, Inc. · Phoenix, Arizona